Replimune (REPL) Tax Rate (2023 - 2026)

Replimune (REPL) posted Tax Rate of 0.39% for Q1 2026, down 6.57% sequentially from 0.42% in Q4 2025, and up 29.0% YoY from 0.3% in Q1 2025.

Replimune (REPL) Tax Rate (2023 - 2026) Analysis & Trends

Replimune has reported Tax Rate for 4 years, with the latest figure at 0.39% in Q1 2026.

Quarterly Tax Rate rose 29.0% year-over-year to 0.39% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.02% (up 23.0% YoY) and the FY2026 annual result came in at 0.19%, up 39.0% from the prior year.
Tax Rate slipped to 0.39% in Q1 2026 per REPL's latest filing, from 0.42% in the prior quarter.
Over five years, Tax Rate peaked at 0.42% in Q4 2025 and troughed at 0.93% in Q4 2023.
A 4-year average of 0.16% and a median of 0.1% in 2025 frame the typical range for Tax Rate.
The widest YoY moves for Tax Rate: up 130 bps in 2025, down 2 bps in 2025.
Over 4 years, Tax Rate stood at 0.93% in 2023, then increased by 6 bps to 0.87% in 2024, then jumped by 148 bps to 0.42% in 2025, then declined by 7 bps to 0.39% in 2026.
According to Business Quant data, Tax Rate over the past three periods registered 0.39%, 0.42%, and 0.1% for Q1 2026, Q4 2025, and Q1 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	15.11%
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.91%
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	24.15%
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-9.47%
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	7.49%
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-16.71%
10	Replimune	1.24 Bn	1.24 Bn	-	0.39%

Download Data